Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Blog  rightarrow COX7B2 sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • MEGF9 blocking peptide blog
 • IGF1 elisa kit blog
 • YWHAH elisa kit blog
 • R-G-D-C peptide blog
 • FOPNL shrna blog
 • IGFBP3 elisa kit blog
 • EPHA2 blocking peptide blog
 • WDFY4 sirna blog
 • ERBB4 sirna blog
 • SRC sirna blog
 • Makisterone A steroid blog
 • SPARCL1 blocking peptide blog
 • anti-HBE1 antibody blog
 • MAPKAP1 shrna blog
 • TSPAN11 sirna blog
 • TCF3 blocking peptide blog
 • anti-H-2Ld (public; H-2.m65) antibody blog
 • IgG1 - IgG1 negative control blog
 • anti-NOTCH 2 antibody blog
 • IL22RA2 shrna blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • Betatrophin (ANGPTL8) Antibody
 • Transient Receptor Potential Cation Channel Subfamily V, Mem... ELISA Kit
 • Vibrio Cholera Toxin A Antibody
 • 15-Deoxy-Prostaglandin J2 (15D-PGJ2) ELISA Kit
 • C4.4A - LYPD3 Antibody
 • ZCCHC11-PAPD3 Antibody
 • EDA Antibody
 • A Disintegrin and Metalloprotease 28 (ADAM28) ELISA Kit
 • Free Thyroxine, FT4 ELISA Kit
 • DCPS Recombinant Protein
 • 40S ribosomal protein S9 (RPS9) Antibody
 • calcitonin gene related peptide, CGRP ELISA Kit
 downarrow more ...

COX7B2 sirna product blog

Posted on 2015-09-03 09:03:39 by mybiosource_staff
Share it on ...     
Tags: COX7B2; siRNA; COX7B2 sirna;
The COX7B2 cox7b2 (Catalog #MBS8223163) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The COX7B2 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s COX7B2 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the COX7B2 cox7b2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The COX7B2 cox7b2 product has the following accession number(s) (GI #115527068) (NCBI Accession #NP_570972.2) (Uniprot Accession #Q8TF08). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

siRNA to inhibit COX7B2 expression using RNA interference.

COX7B2 cox7b2

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human COX7B2 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo. The following patways have been known to be associated with this gene.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions